OSD Manufacturing Operator II – Tablets & Capsules (Onsite)

Novartis AG; Morrisville (NC); On-site; USD 38,000 - 71,000; Full time

Job summary

Novartis is seeking a Manufacturing Operator II for Oral Solid Dosage (OSD) at the new Morrisville site. You will execute manufacturing activities for tablets and capsules in a state-of-the-art GMP environment and contribute to a growing team.

The role requires hands-on experience with OSD processes, strong GMP/documentation practices, and collaboration across Operations and QA to ensure quality and regulatory readiness. On-site, day shift with opportunities to impact patients globally.

Qualifications

• Bachelor's degree in a scientific field and 2+ years cGMP manufacturing experience.
• Hands-on experience in Oral Solid Dosage production (tablet and capsule).
• Experience operating equipment in an FDA-regulated environment.
• GMP documentation and batch record handling proficiency.

Responsibilities

• Execute OSD manufacturing activities per production schedules.
• Operate, monitor, and troubleshoot tablet and capsule equipment.
• Perform granulation, compression, coating, and encapsulation steps.
• Complete batch records accurately and on time per GMP.
• Set up equipment, clean lines, and prepare rooms as needed.
• Conduct in-process checks, sampling, and monitoring.

Skills

GMP compliance

Good Documentation

HSE policy

Manufacturing processes

Quality control

Regulatory compliance

Education

Bachelor's degree in Biology, Chemistry, Biotechnology or related field

Tools

OSD equipment (tablet/capsule)

Job description

Novartis is seeking a Manufacturing Operator II for Oral Solid Dosage (OSD) at the new Morrisville site. You will execute manufacturing activities for tablets and capsules in a state-of-the-art GMP environment and contribute to a growing team.

The role requires hands-on experience with OSD processes, strong GMP/documentation practices, and collaboration across Operations and QA to ensure quality and regulatory readiness. On-site, day shift with opportunities to impact patients globally.